Oncotelic Therapeutics, Inc. (OTCMKTS:OTLC – Get Free Report) was the target of a significant growth in short interest in April. As of April 15th, there was short interest totalling 11,400 shares, a growth of 2,750.0% from the March 31st total of 400 shares. Based on an average trading volume of 206,900 shares, the short-interest ratio is currently 0.1 days.
Oncotelic Therapeutics Stock Performance
OTCMKTS:OTLC remained flat at $0.04 during trading hours on Thursday. The company had a trading volume of 10,259 shares, compared to its average volume of 71,367. The firm has a fifty day moving average of $0.04 and a 200 day moving average of $0.04. The company has a debt-to-equity ratio of 0.16, a current ratio of 0.02 and a quick ratio of 0.02. Oncotelic Therapeutics has a 1-year low of $0.01 and a 1-year high of $0.05.
About Oncotelic Therapeutics
See Also
- Five stocks we like better than Oncotelic Therapeutics
- What is a SEC Filing?
- Hasbro’s Management Made All the Right Calls This Quarter
- 3 Warren Buffett Stocks to Buy Now
- Caterpillar’s Market Reset Isn’t Over: Get Ready for Lower Prices
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Power Surge: Utilities Sector’s Resilience Shines
Receive News & Ratings for Oncotelic Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oncotelic Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.